deltatrials
Completed NA INTERVENTIONAL 2-arm NCT03993769

CSD190101: A Study to Assess Nicotine Pharmacokinetic Parameters After Use of Two Smokeless Tobacco Products

CSD190101: An Unblinded, Randomized, Multi-site, Two-way Crossover Study to Assess Nicotine Pharmacokinetic Parameters After Use of Two Smokeless Tobacco Products A19010-F and B19010-F in Healthy Adult Snus Consumers.

Sponsor: Celerion

Conditions Tobacco Use
Interventions A19010-F B19010-F
Updated 5 times since 2019 Last updated: Oct 24, 2019 Started: Jul 9, 2019 Primary completion: Aug 31, 2019 Completion: Aug 31, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Tobacco Use, this trial is completed. The trial is conducted by Celerion and has accumulated 5 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jul 2019 – ~Nov 2019 · 4 months · monthly snapshotRecruiting~Nov 2019 – ~Jan 2021 · 14 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 24 months · monthly snapshotCompleted

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  4. Nov 2019 — Jan 2021 [monthly]

    Completed NA

    Status: Recruiting → Completed

  5. Jul 2019 — Nov 2019 [monthly]

    Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Celerion
  • RAI Services Company
Data source: RAI Services Company

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations